Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $3.8 million.

  • Palisade Bio's Total Liabilities rose 3786.66% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 3786.66%. This contributed to the annual value of $3.4 million for FY2024, which is 2369.48% up from last year.
  • As of Q3 2025, Palisade Bio's Total Liabilities stood at $3.8 million, which was up 3786.66% from $4.0 million recorded in Q2 2025.
  • Palisade Bio's Total Liabilities' 5-year high stood at $24.4 million during Q2 2021, with a 5-year trough of $1.2 million in Q1 2021.
  • For the 5-year period, Palisade Bio's Total Liabilities averaged around $4.7 million, with its median value being $3.1 million (2022).
  • Per our database at Business Quant, Palisade Bio's Total Liabilities surged by 271229.79% in 2021 and then plummeted by 8526.22% in 2022.
  • Palisade Bio's Total Liabilities (Quarter) stood at $12.4 million in 2021, then plummeted by 73.42% to $3.3 million in 2022, then dropped by 16.6% to $2.7 million in 2023, then increased by 23.69% to $3.4 million in 2024, then grew by 11.01% to $3.8 million in 2025.
  • Its Total Liabilities stands at $3.8 million for Q3 2025, versus $4.0 million for Q2 2025 and $2.9 million for Q1 2025.